| |
|
|
|
|
|
|
|||
|
SJ Greenberg, ES Jaffe, GD Ehrlich, NJ Korman, BJ Poiesz and TA Waldmann
Metabolism Branch, National Cancer Institute, National Institutes of
Health, Bethesda, MD 20892.
Kaposi's sarcoma (KS) developed in a patient with human T-cell leukemia
virus type I (HTLV-I)-associated adult T-cell leukemia who was treated with
a short-term course of monoclonal antibody immunotherapy. The presentation
was transient and temporally related to the underlying clinical course. The
association of KS in an HTLV-I infected, but not human immunodeficiency
virus (HIV)-infected, individual should alert investigators to the
occurrence of KS in retroviral-associated diseases other than acquired
immunodeficiency disease syndrome. Recognition of the similarities and
differences between HTLV-I and HIV infections may provide insights
concerning the angiopathogenesis of KS.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1990 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||